(781) 725-0505
Contact
Medical

Botox for TMJ

Temporomandibular joint (TMJ) disorders are a common source of jaw pain, facial tension, headaches, and teeth grinding. For many patients, symptoms are driven by overactive jaw muscles, particularly the masseter and temporalis muscles, which place excessive strain on the jaw joint. Neurotoxin treatment has emerged as an effective, non-surgical option to relieve these symptoms by reducing muscle overactivity and restoring functional balance.

At Vue Dermatology & Laser, neurotoxin injections for TMJ are performed by a board-certified dermatologist with a detailed understanding of facial anatomy, muscle dynamics, and safe injection techniques.

The temporomandibular joint connects your jaw to your skull and allows for essential movements like chewing, speaking, and yawning. TMJ disorders occur when this joint, or the muscles controlling it, becomes irritated or dysfunctional.

Common symptoms include:

  • Jaw pain or tightness
  • Clicking or popping with jaw movement
  • Facial pain or pressure
  • Headaches or migraines
  • Teeth grinding or clenching (bruxism)
  • Jaw fatigue or locking

In many patients, chronic clenching and grinding cause the jaw muscles to become enlarged and hyperactive, perpetuating pain and inflammation.

Neurotoxins work by temporarily relaxing targeted muscles. When injected into the masseter and sometimes the temporalis muscles, they reduce excessive muscle contraction while still preserving normal jaw function.

By decreasing muscle tension, neurotoxin treatment can:

  • Relieve jaw pain and facial tightness
  • Reduce clenching and grinding
  • Lessen headache frequency
  • Decrease stress on the jaw itself
  • Improve overall comfort with chewing and speaking

This approach treats the muscular driver of TMJ symptoms rather than simply masking pain.

During your TMJ neurotoxin treatment visit:

  • Your jaw muscles are evaluated at rest and during clenching
  • Injection sites are carefully mapped for precision
  • A series of small injections are placed into the targeted muscles

Most patients describe the injections as mildly uncomfortable but very tolerable. No anesthesia is required.

Relief is not immediate. Most patients begin noticing improvement within 1–2 weeks, with peak benefit at about 4–6 weeks.

Results typically last 3–4 months for most patients. Some patients experience longer-lasting relief with repeated treatments and as muscle activity decreases over time, some individuals find they require lower doses or less frequent treatments.

While the primary goal is pain relief, relaxing the masseter muscles may also soften a bulky or square jawline caused by muscle hypertrophy. This can result in a slimmer lower-face appearance for some patients. Any aesthetic change is gradual and subtle, and treatment is always tailored first and foremost to function and comfort.

You may be a good candidate if you:

  • Have jaw pain related to clenching or grinding
  • Experience TMJ-related headaches or facial pain
  • Have not found sufficient relief with night guards or physical therapy
  • Prefer a non-surgical, minimally invasive option

Neurotoxin treatment can be used alone or in combination with other TMJ therapies, such as dental appliances, stress reduction, or physical therapy.

TMJ injections require a precise understanding of facial musculature to ensure effective relief while preserving normal jaw function. When performed by a board-certified dermatologist, neurotoxin treatment is safe, well-tolerated, and highly targeted.

Side effects are uncommon but may include temporary soreness, mild weakness with chewing tough foods, or localized bruising—all of which typically resolve on their own.

If jaw pain, clenching, or TMJ symptoms are affecting your quality of life, neurotoxin treatment may offer meaningful relief. A personalized consultation at Vue Dermatology & Laser allows for a comprehensive evaluation and a treatment plan tailored to your symptoms and anatomy.

At a Glance

Philip Eliades, MD, FAAD

  • Board-Certified Dermatologist
  • Served as Chief Resident at NewYork-Presbyterian Hospital/Weill Cornell Medical Center and Memorial Sloan Kettering Cancer Center
  • Author of numerous peer-reviewed research articles in leading Dermatology journals
  • Learn more